These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9754589)

  • 21. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
    Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
    Guazzi M; Melzi G; Marenzi GC; Agostoni P
    Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
    Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
    Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
    Guazzi M; Marenzi G; Alimento M; Contini M; Agostoni P
    Circulation; 1997 Apr; 95(7):1930-6. PubMed ID: 9107182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
    Morawietz H; Rohrbach S; Rueckschloss U; Schellenberger E; Hakim K; Zerkowski HR; Kojda G; Darmer D; Holtz J
    Eur J Clin Invest; 2006 Oct; 36(10):705-12. PubMed ID: 16968466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [I/D angiotensin-converting enzyme gene polymorphism: structural changes in the myocardium and predictive value in chronic heart failure].
    Voronkov LH; Horovenko NH; Mazur ID; Liashenko AV
    Lik Sprava; 2012 Dec; (8):36-42. PubMed ID: 23786008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism.
    Contini M; Compagnino E; Cattadori G; Magrì D; Camera M; Apostolo A; Farina S; Palermo P; Gertow K; Tremoli E; Fiorentini C; Agostoni P
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):159-68. PubMed ID: 26847573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial infarction increases ACE2 expression in rat and humans.
    Burrell LM; Risvanis J; Kubota E; Dean RG; MacDonald PS; Lu S; Tikellis C; Grant SL; Lew RA; Smith AI; Cooper ME; Johnston CI
    Eur Heart J; 2005 Feb; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment.
    Kelly MP; Kahr O; Aalkjaer C; Cumin F; Samani NJ
    Clin Sci (Lond); 1997 May; 92(5):455-65. PubMed ID: 9176018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
    Zhuo JL; Mendelsohn FA; Ohishi M
    Hypertension; 2002 Feb; 39(2 Pt 2):634-8. PubMed ID: 11882622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment].
    Tepliakov AT; Shilov SN; Berezikova EN; Efremov AV; Safronov ID; Pustovetova MG; Maianskaia SD; Torim IuIu; Karpov RS
    Kardiologiia; 2013; 53(3):9-14. PubMed ID: 23548421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
    Lear W; Ruzicka M; Leenen FH
    Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
    Woie L; Dickstein K; Kaada B
    Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
    Shah KR; Ganguly PK; Netticadan T; Arneja AS; Dhalla NS
    Can J Physiol Pharmacol; 2004 Jul; 82(7):438-47. PubMed ID: 15389290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.